Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/1996
09/03/1996CA2059632C Reveromycin a, method for preparing same, and antitumor agent and antifungal agent comprising the same
08/1996
08/29/1996WO1996026272A1 Prostate-specific membrane antigen and uses thereof
08/29/1996WO1996026271A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof
08/29/1996WO1996026214A1 Isolated nonapeptides presented by hla molecules, and uses thereof
08/29/1996WO1996026201A1 Benzopyran-containing compounds and method for their use
08/29/1996WO1996025949A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors
08/29/1996WO1996025941A1 Modulators of regulatory proteins
08/29/1996WO1996019580A3 Telomerase protein component
08/29/1996CA2213484A1 Modulators of regulatory proteins
08/29/1996CA2213451A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof
08/29/1996CA2213337A1 Isolated nonapeptides presented by hla molecules, and uses thereof
08/29/1996CA2212846A1 Prostate-specific membrane antigen and uses thereof
08/29/1996CA2210320A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors
08/29/1996CA2170480A1 Methods of inhibiting estrogen positive tumors of the brain or cns
08/29/1996CA2170337A1 Naphthyl compounds, intermediates, compositions, and methods
08/29/1996CA2169414A1 Phosphorous-containing benzothiophenes
08/28/1996EP0728763A1 Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor
08/28/1996EP0728758A1 Dioxopyrrolo-pyrrole derivatives
08/28/1996EP0728742A2 Novel retinoids
08/28/1996EP0728739A1 Biaromatic amide derivatives, pharmaceutical and cosmetic compositions containing them and their utilisations
08/28/1996EP0728738A1 Tetralinyl- and indanyl-ethylamides having melatonergic activity
08/28/1996EP0728210A1 Thrombin mutants
08/28/1996EP0728202A1 Episomal expression vector for human gene therapy
08/28/1996EP0728144A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
08/28/1996EP0728143A1 Oncoprotein protein kinase
08/28/1996EP0728131A1 Novel taxoids, their preparation and pharmaceutical compositions containing them
08/28/1996EP0728012A1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
08/28/1996EP0728009A1 Use of an agent which modulates tyrosine phosphorylation for modulating the permeability of a psychological barrier
08/28/1996EP0728005A1 Methylene blue for the treatment or prophylaxis of ancephalopathy caused by ifosfamide
08/28/1996EP0727999A1 Treatment of immunoregulatory disorders
08/28/1996EP0727989A1 Butyric ester cyto-differentiating agents
08/28/1996EP0727984A1 Controlled release preparation
08/28/1996EP0727942A1 Methods of achieving antileukemia activity using 16-membered-macrolide-type compounds
08/28/1996EP0727941A1 Methods of achieving antitumor activity using 16-membered-macrolide-type compounds
08/28/1996EP0621862B1 Organic salts of n, n'-diacetyl cystine
08/28/1996EP0582711B1 Ketotricyclo(5.2.1.0)decane derivates
08/28/1996EP0571407B1 Cloning of a new member of the fibroblast growth factor (fgf) receptor family
08/28/1996EP0565519B1 Illudin analogs as anti-tumor agents
08/28/1996EP0523100B1 O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing o6 -alkylguanine-dna alkyltransferase depleting activity
08/28/1996EP0406297B1 Medical use of neuropeptide Antagonist G
08/28/1996CN1129955A A truncated keratinocyte growth factor (KGF) having increased biological activity
08/28/1996CN1129941A Substituted azaindolylidene compounds and process for their preparation
08/28/1996CN1129940A Bicyclic tetrahydro pyrazolopyridines
08/27/1996US5550261 Taxoids, their preparation and pharmaceutical compositions containing them
08/27/1996US5550216 Gelatinase A inhibitor, and analytical reagent thereof for the determination of gelatinase A
08/27/1996US5550212 Analogues of hGH-RH(1-29)NH2 having antagonistic activity
08/27/1996US5550164 Method for inhibiting uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
08/27/1996US5550149 Sulfur-containing compounds that are effective in potentiating the activity of chemotherapeutic anti-cancer agents by increasing sensitivity of multi-drug resistant cells
08/27/1996US5550142 Phenyl heterocycles as cox-2 inhibitors
08/27/1996US5550139 Serine protease inhibitors
08/27/1996US5550110 Pentapeptide and hexapeptide analogs of endothelin-1
08/27/1996US5550107 Anticarcinogenic agents and antiestrogens
08/27/1996US5550019 Methods of identifying compounds which alter apoptosis
08/27/1996US5549915 Magnetically responsive composition for carrying biologically active substances and methods of production
08/27/1996CA2135890C Retroviral protease inhibitor (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4- thiazolyl)methyl)amino)carbonyl)valinyl)amino)- 2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1, 6-diphenyl-3-hydroxyhexane
08/27/1996CA1338561C Aromatic esters and thioesters; process for preparing the same and their use in human or animal medecine and in cosmetics
08/25/1996CA2170227A1 Novel retinoids
08/22/1996WO1996025666A1 NF-λB ACTIVATION REGULATORY PROTEIN, IλB-BETA
08/22/1996WO1996025511A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF
08/22/1996WO1996025502A1 Calcineurin regulatable adenylate cyclase
08/22/1996WO1996025499A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer
08/22/1996WO1996025494A1 Transcription factor - e2f-5
08/22/1996WO1996025493A1 Multiple-tumor aberrant growth genes
08/22/1996WO1996025434A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION
08/22/1996WO1996025423A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996WO1996025422A1 Keratinocyte growth factor-2
08/22/1996WO1996025405A1 Substituted isoxazoles for the treatment of inflammation
08/22/1996WO1996025392A1 Novel borneol derivatives, methods of manufacturing them, and their pharmaceutical use
08/22/1996WO1996025171A1 Inhibition of angiogenesis using interleukin-12
08/22/1996WO1996025159A1 A method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds
08/22/1996DE19506885A1 Neue Borneolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung New Borneolderivate, processes for their preparation and their pharmaceutical use
08/22/1996CA2213315A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity
08/22/1996CA2213237A1 Multiple-tumor aberrant growth genes
08/22/1996CA2213233A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer
08/22/1996CA2213229A1 Peptides and peptidomimetics with structural similarity to human p53 that activate p53 function
08/22/1996CA2213211A1 New borneol derivatives, process for their production, and their pharmaceutical use
08/22/1996CA2212370A1 Inhibition of angiogenesis using interleukin-12
08/22/1996CA2211975A1 Transcription factor - e2f-5
08/22/1996CA2210441A1 Nf-.kappa.b activation regulatory protein, i.kappa.b-beta
08/21/1996EP0727486A2 Tumour suppressor gene
08/21/1996EP0727433A1 Process for the preparation of 1-(2'-deoxy-2',2'-difluoro-d-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-beta-d-ribo-pentopyranose
08/21/1996EP0727430A1 Improvements in PT complexes
08/21/1996EP0727425A1 Adhesion receptor antagonists
08/21/1996EP0727419A2 Retroviral protease inhibiting compounds
08/21/1996EP0727206A2 The use of sertraline to treat cancer patients
08/21/1996EP0726954A1 Cntf family antagonists
08/21/1996EP0726941A1 METHODS FOR $i(EX VIVO) THERAPY USING PEPTIDE-LOADED ANTIGEN PRESENTING CELLS FOR THE ACTIVATION OF CTL
08/21/1996EP0726914A1 Cell surface protein expressed on human cortical thymocyte and their use
08/21/1996EP0726911A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
08/21/1996EP0726908A1 Oncoprotein protein kinase
08/21/1996EP0726904A1 5-fluorouracil derivatives
08/21/1996EP0726899A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments
08/21/1996EP0726773A1 Method for inhibiting angiogenesis using heparinase
08/21/1996EP0726772A1 A method for sensitization of cancer cells for killer cell mediated lysis
08/21/1996EP0726768A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
08/21/1996EP0660723B1 Vp6 encapsulated drug delivery
08/21/1996EP0614457B1 Leukotriene-b 4? derivatives, process for preparing the same and medicaments
08/21/1996EP0589949B1 New peptides (didemnins), their preparation and their use
08/21/1996EP0512002B1 Cell-specific enzyme-conjugates for the release of toxic cyanide from cyanogenic prodrugs at target cells
08/21/1996CN1129442A Benzodiazepine compounds useful as antagonisis of cck or of gastrine
1 ... 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 ... 2211